191 related articles for article (PubMed ID: 26757432)
1. The relationship between EMT, CD44
Johansson AC; La Fleur L; Melissaridou S; Roberg K
J Oral Pathol Med; 2016 Oct; 45(9):640-646. PubMed ID: 26757432
[TBL] [Abstract][Full Text] [Related]
2. A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.
La Fleur L; Johansson AC; Roberg K
PLoS One; 2012; 7(9):e44071. PubMed ID: 23049743
[TBL] [Abstract][Full Text] [Related]
3. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
[TBL] [Abstract][Full Text] [Related]
4. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells.
Wiechec E; Hansson KT; Alexandersson L; Jönsson JI; Roberg K
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468237
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
[TBL] [Abstract][Full Text] [Related]
7. FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition.
Brown WS; Akhand SS; Wendt MK
Oncotarget; 2016 Dec; 7(50):83424-83436. PubMed ID: 27825137
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal-transition induced by EGFR activation interferes with cell migration and response to irradiation and cetuximab in head and neck cancer cells.
Holz C; Niehr F; Boyko M; Hristozova T; Distel L; Budach V; Tinhofer I
Radiother Oncol; 2011 Oct; 101(1):158-64. PubMed ID: 21665310
[TBL] [Abstract][Full Text] [Related]
9. Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells.
Oh BY; Kim SY; Lee YS; Hong HK; Kim TW; Kim SH; Lee WY; Cho YB
Oncotarget; 2016 Aug; 7(35):57066-57076. PubMed ID: 27494849
[TBL] [Abstract][Full Text] [Related]
10. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
11. Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation.
Yang WH; Su YH; Hsu WH; Wang CC; Arbiser JL; Yang MH
Oncogene; 2016 May; 35(18):2287-98. PubMed ID: 26257063
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma.
Mahmoudian RA; Gharaie ML; Abbaszadegan MR; Alasti A; Forghanifard MM; Mansouri A; Gholamin M
Mol Cell Biochem; 2021 Jun; 476(6):2465-2478. PubMed ID: 33604811
[TBL] [Abstract][Full Text] [Related]
13. Snail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cells.
Masui T; Ota I; Yook JI; Mikami S; Yane K; Yamanaka T; Hosoi H
Int J Oncol; 2014 Mar; 44(3):693-9. PubMed ID: 24365974
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
15. EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines.
Jedlinski A; Ansell A; Johansson AC; Roberg K
J Oral Pathol Med; 2013 Jan; 42(1):26-36. PubMed ID: 22643066
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-Mesenchymal Transition during Metastasis of HPV-Negative Pharyngeal Squamous Cell Carcinoma.
Ihler F; Gratz R; Wolff HA; Weiss BG; Bertlich M; Kitz J; Salinas G; Rave-Fränk M; Canis M
Biomed Res Int; 2018; 2018():7929104. PubMed ID: 29693014
[TBL] [Abstract][Full Text] [Related]
17. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.
Bruzzese F; Leone A; Rocco M; Carbone C; Piro G; Caraglia M; Di Gennaro E; Budillon A
J Cell Physiol; 2011 Sep; 226(9):2378-90. PubMed ID: 21660961
[TBL] [Abstract][Full Text] [Related]
18. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
[TBL] [Abstract][Full Text] [Related]
19. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
20. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]